Literature DB >> 31480898

Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.

Sameer Prasada1, Sanjiv J Shah2, Erin D Michos3, Joseph F Polak4, Philip Greenland5.   

Abstract

This study investigated the relationship between ankle-brachial index (ABI) and risk for heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF). ABI has previously been associated with mortality, cardiovascular disease (CVD), and overall HF but the relationship between ABI and risk of HF stratified by EF has not been well characterized. We analyzed data from 6553 participants (53% female; mean age 62 ± 10 years) enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA) who were free of known clinical CVD/HF at baseline (2000-2002) and had baseline ABI measured. Participants were classified as low (≤ 0.90), borderline-low (0.91-1.00), normal (1.01-1.40), and high (> 1.40) ABI. Incident hospitalized HF was determined over a median follow-up of 14 years; we classified HF events (n = 321) as HFrEF with EF < 50% (n = 155, 54%) or HFpEF with EF ⩾ 50% (n = 133, 46%). Low ABI was associated with incident HFrEF (hazard ratio (HR): 2.02, 95% CI 1.19-3.40, p = 0.01) and had no significant association with HFpEF (HR: 0.67, 95% CI 0.30-1.48, p = 0.32). Borderline-low and high ABI were not significantly associated with HFrEF or HFpEF. Cubic spline analyses showed association with both low and high ABI for HFrEF and high ABI for HFpEF. A 1 SD lower ABI (for ABI < 1.1) was associated with incident HFrEF in multivariable analysis (HR: 1.27, 95% CI 1.05-1.54) but was not significant after additionally adjusting for interim myocardial infarction (HR: 1.21, 95% CI 0.99-1.48). Low ABI was associated with higher risk for incident HFrEF but not HFpEF in persons free of known CVD. Future studies of a larger size are needed for high ABI analyses.

Entities:  

Keywords:  ankle–brachial index (ABI); heart failure with preserved ejection fraction (HFpEF); heart failure with reduced ejection fraction (HFrEF); incident heart failure; peripheral artery disease (PAD)

Mesh:

Year:  2019        PMID: 31480898     DOI: 10.1177/1358863X19870602

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  4 in total

1.  Cardiac Rehabilitation and Mortality Risk Reduction in Peripheral Artery Disease at 6-Month Outcome.

Authors:  Razvan Anghel; Cristina Andreea Adam; Ovidiu Mitu; Dragos Traian Marius Marcu; Viviana Onofrei; Mihai Roca; Alexandru Dan Costache; Radu Stefan Miftode; Grigore Tinica; Florin Mitu
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort.

Authors:  Lena Makowski; Jeanette Köppe; Christiane Engelbertz; Leonie Kühnemund; Alicia J Fischer; Stefan A Lange; Patrik Dröge; Thomas Ruhnke; Christian Günster; Nasser Malyar; Joachim Gerß; Eva Freisinger; Holger Reinecke; Jannik Feld
Journal:  Eur Heart J       Date:  2022-05-07       Impact factor: 35.855

3.  Epidemiology of Peripheral Artery Disease and Polyvascular Disease.

Authors:  Aaron W Aday; Kunihiro Matsushita
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

4.  The high normal ankle brachial index is associated with left ventricular hypertrophy in hypertension patients among the Han Chinese.

Authors:  Jin Sun; Shuxia Wang; Man Li; Yongkang Su; Shouyuan Ma; Yan Zhang; Anhang Zhang; Shuang Cai; Bokai Cheng; Qiligeer Bao; Ping Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-23       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.